Objective To investigate the association of non-steroidal anti-inflammatory drugs (NSAIDs) and the risk of atrial fibrillation in a prospective community-based follow-up study of elderly individuals ...

β-blockers are effective ventricular antiarrhythmics and angiotensin-converting-enzyme (ACE) inhibitors can prevent both ventricular and atrial arrhythmia after MI. The effect of β-blockers on ...

Accelerated Adoption of vMap Across Arrhythmia Types In 2024, vMap demonstrated significant clinical uptake across both new and existing sites, proving its unique value and utility in a market flooded ...

Inter-atrial and right intra-atrial conduction delays were observed. The IBD population has an increased risk for left ventricular and atrial dysfunction, vascular changes, arrhythmias, and HF ...

Short-term follow-up included hospitalisation within 3 months for atrial arrhythmia or procedure-related complications (to allow for late-presenting complications such as atrio-oesophageal fistula).

Atrial fibrillation (AF) is the most frequent type of cardiac arrhythmia, affecting 5% of the population over 65 years old and increasing exponentially thereafter. AF results in a 5‐fold increased ...

Those who underwent non-PV trigger provocative maneuvers or had spontaneous non-PV trigger firing were included. Non-PV triggers were defined as non-PV ectopic beats triggering AF or sustained focal ...

Pulsed field ablation (PFA) is a promising treatment for atrial fibrillation. We report 1-year freedom from atrial arrhythmia outcomes using monopolar PFA delivered through 3 commercial, contact force ...

Atrial fibrillation (AF), the most prevalent cardiac arrhythmia, is closely linked to metabolic dysfunctions, including obesity, diabetes, and dyslipidemia. These lead to pathological changes in ...

System for the treatment of paroxysmal atrial fibrillation as part of the VISION AF clinical trial. Dr. Vivek Reddy, Director of Cardiac Arrhythmia Services at Mount Sinai Hospital and Prof.

In the U.S., atrial fibrillation (AF), a heart condition ... (a subcutaneous device that continuously monitors heart rhythm for about four years), found AF was diagnosed in a third of patients ...